FDA Inspection 1252564 — OU Health

OU Health — FEI 3001451718

The FDA completed an inspection of OU Health on October 28, 2024 in Oklahoma City, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 28, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Oklahoma City, OK (United States)

Citations

IDCFRDescription
1223621 CFR 1271.55(a)(2)Eligibility statement--basis of determination